Skip to main content

Advertisement

Table 2 Demographic and clinicopathological characteristics of participants

From: The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

Parameters PTC (%) MNG (%) Total (%)
Patients 60 (66.7) 30 (33.3) 90 (100)
Age
 < 45 years 43 (71.7) 10 (33.3) 53 (58.9)
 ≥45 years 15 (25.0) 17 (56.7) 32 (35.6)
Sex
 Male 15 (25.0) 5 (16.7) 20 (22.2)
 Female 45 (75.0) 25 (83.3) 70 (77.8)
BRAF V600E mutation
 BRAF (+) 24 (40.0)
 BRAF (−) 36 (60.0)
Tumor size
 < 2 cm 37 (61.7)
 ≥2 cm 20 (33.3)
TNM Staging
 I 46 (76.7)
 II 3 (5.0)
 III 7 (11.7)
 IV 2 (3.3)
Focality Status
 Unifocal 11 (18.3)
 Multifocality 19 (31.7)
Extracapsular invasion
 Yes 14 (23.3)
 No 45 (75.0)
LNM
 Yes 27 (45.0)
 No 32 (53.3)
Lymphovascular invasion
 Yes 8 (13.3)
 No 51 (85.0)
Variant
 Classic 50 (55.6)
 Follicular 7 (7.8)
 Hürthle cell 1 (1.1)
 Sclerosing 1 (1.1)
  1. TNM tumor node metastasis, LNM lymph node metastasis